Innoviva
Funds hospital critical-care and infectious-disease drugs with GSK respiratory royalties.
$20.97
After-hours close+0.01 (+0.05%)
At close$20.96(0.00%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 105.31%Insiders 1.24%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 73.81M · Float 69.20M · 93.8% free float
Institutions13F, as of Jun 30, 2026
309 holders · 77.72M shares · 47 new positions · 180 increased · 84 reduced · 24 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 11.56M | 15.66% | +247.4K | Aug 7, 2026 |
| Dimensional Fund Advisors LP | 4.49M | 6.09% | +57.6K | Aug 11, 2026 |
| Vanguard Portfolio Management LLC | 4.22M | 5.72% | −4.7K | Aug 13, 2026 |
| Renaissance Technologies LLC | 4.04M | 5.47% | −19.1K | Aug 13, 2026 |
| State Street Corp | 3.27M | 4.43% | +207.6K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 3.16M | 4.28% | +16.5K | Aug 13, 2026 |
| Millennium Management LLC | 2.54M | 3.44% | +261.7K | Aug 14, 2026 |
| Geode Capital Management, LLC | 2.07M | 2.81% | +145.0K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.00% | 8.79M | 13G | Apr 28, 2025 ↗ |
| Dimensional Fund Advisors LP | 5.80% | 4.36M | 13G | Jan 21, 2026 ↗ |
| Vanguard Portfolio Management | 5.79% | 4.29M | 13G | Apr 29, 2026 ↗ |
| Renaissance Technologies LLC | 5.63% | 4.21M | 13G | Feb 12, 2026 ↗ |
| Vanguard Capital Management | 5.01% | 3.70M | 13G | Jul 31, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Denner Alexander J | 10 percent owner | 5.66M | 7.67% | Mar 6, 2025 |
| Pavel Raifeld | director, officer: Chief Executive Officer | 284.8K | 0.39% | Aug 24, 2026 |
| Jules Haimovitz | director | 152.7K | 0.21% | May 6, 2026 |
| Mark DiPaolo | director | 140.5K | 0.19% | May 6, 2026 |
| Sarah J. Schlesinger | director | 140.5K | 0.19% | May 6, 2026 |
| Stephen Basso | officer: Chief Financial Officer | 88.0K | 0.12% | Aug 24, 2026 |
| Marianne Zhen | officer: Chief Accounting Officer | 56.4K | 0.08% | Aug 24, 2026 |
| Derek A. Small | director | 45.0K | 0.06% | May 6, 2026 |
| Josephine Linden | director | 5.7K | 0.01% | May 20, 2026 |
1 ten-percent owner holds 5.66M shares by Form 4, outside the officers-and-directors figure above · 38 people have not refiled in the last 18 months (7.70M shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.